| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/30/1986 | US4632907 Albumin, glycerol or dmso stabilizer, sodium azide or thimerosol preventative |
| 12/30/1986 | US4632761 Centrifugal microconcentrator and methods for its use |
| 12/30/1986 | EP0206939A1 Expression of human IL-2 in mammalian cells by a recombined pox virus |
| 12/30/1986 | EP0206920A1 Expression vector for gamma interferon in cells of mammals, process for its use, product obtained and pharmaceutical composition containing gamma interferon |
| 12/30/1986 | EP0206863A1 Non-amidated derivatives of somatocrinine and process for the preparation by genetic engineering |
| 12/30/1986 | EP0206858A1 Process for the synthesis of macromolecular derivatives of nicotinamide adenine |
| 12/30/1986 | EP0206842A1 Antigens related to the envelope glycoprotein of the acquired immunodeficiency syndrome virus |
| 12/30/1986 | EP0206801A2 Tissue-affinitive collagen for osteogenesis and method of producing the same |
| 12/30/1986 | EP0206769A2 A process for the production of alpha-human atrial natriuretic polypeptide |
| 12/30/1986 | EP0206741A2 Leukotriene antagonists |
| 12/30/1986 | EP0206730A2 Vasopressin antagonists |
| 12/30/1986 | EP0206729A2 Pharmacologically active compounds |
| 12/30/1986 | EP0206719A2 Treatment fo autoimmune diseases such as rheumatoid arthritis with suppressor factor |
| 12/30/1986 | EP0206625A2 Compositions for the treatment of gastrointestinal disorders |
| 12/30/1986 | EP0206533A2 Platelet inhibiting monoclonal antibody fragment |
| 12/30/1986 | EP0206532A2 Fibrinogen blocking monoclonal antibody |
| 12/30/1986 | EP0206448A1 Hemoglobin combined with a poly(alkylene oxide) |
| 12/30/1986 | EP0206400A1 New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies |
| 12/30/1986 | EP0206313A2 Chloro-substituted ketone imidazole derivatives |
| 12/30/1986 | EP0206302A2 New Assay and purification of amyloid components, applications, and kits therefor |
| 12/30/1986 | EP0206200A2 Human cholinesterase-type proteins and their production |
| 12/30/1986 | EP0206159A2 Process for the preparation of thermostable structured layers, and their use |
| 12/30/1986 | EP0206118A2 Cyclic hexapeptide somatostatin analogs, process for their preparation and pharmaceutical compositions containing them |
| 12/30/1986 | EP0206090A2 Peptide renin inhibitors |
| 12/30/1986 | EP0205629A1 Use of preparations containing gamma interferon (IFN-gamma) for treating rheumatic diseases |
| 12/30/1986 | EP0205555A1 Serine protease inhibitors and methods for isolation of same. |
| 12/30/1986 | CA1215919A1 Detection of malignant tumor cells |
| 12/30/1986 | CA1215918A1 Suppressive factor of allergy |
| 12/30/1986 | CA1215904A1 Method for detection identification and quantitation of non-viral organisms |
| 12/23/1986 | US4631270 Therapeutically useful pseudopeptides, compositions containing the same and methods of preparation and use |
| 12/23/1986 | US4631256 From actinomycin-antibiotic, antitumor agent |
| 12/23/1986 | CA1215645A1 Method of regulating appetite and efficiency of food utilization employing interferon |
| 12/18/1986 | WO1986007384A1 Process for preparing hapatitis b virus surface antigen p31 |
| 12/18/1986 | WO1986007382A1 Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a |
| 12/18/1986 | WO1986007263A1 Bradykinin antagonist peptides |
| 12/17/1986 | EP0205405A2 Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications |
| 12/17/1986 | EP0205404A2 Hybrid interferons |
| 12/17/1986 | EP0205270A2 Radiolabeled antiplatelet monoclonal antibody for imaging in vivo thrombi |
| 12/17/1986 | EP0205247A2 Derivatives of quinuclidine |
| 12/17/1986 | EP0205209A2 Decapeptides having hypotensive action and process for their preparation |
| 12/17/1986 | EP0205051A1 A pharmaceutical composition in the form of a cream for dermal and ophthalmic use |
| 12/17/1986 | EP0205038A1 Polypeptide, process for preparing it, microorganism and pharmaceutical use |
| 12/17/1986 | EP0204798A1 Monoclonal antibodies and their use |
| 12/17/1986 | EP0204788A1 New hypocalcemic polypeptides, preparation thereof and drugs containing these active principles. |
| 12/17/1986 | EP0204775A1 Amino acid and peptide inhibitors of human leucocytic elastase |
| 12/17/1986 | CN86104835A Vasopressin antagonists |
| 12/16/1986 | USRE32311 Derivatives of A-21978C cyclic peptides |
| 12/16/1986 | USRE32310 Antibiotics |
| 12/16/1986 | US4629787 Angiotensin converting enzyme inhibitors |
| 12/16/1986 | US4629783 Polypeptides |
| 12/16/1986 | US4629773 Imidylcompounds, polymers therefrom, and use of the polymers |
| 12/16/1986 | US4629724 Amino acid ester and amide renin inhibitors |
| 12/16/1986 | US4629723 Potent thymopentin analogs |
| 12/16/1986 | CA1215356A1 Process for the total or partial elimination of aspartic acid and glutamic acid from protein hydrolyzates and mixtures of aminoacids, and aminoacid compositions therefrom having high nutritive value |
| 12/16/1986 | CA1215331A1 Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy |
| 12/10/1986 | EP0204589A2 Glutathione monoalkyl ester sulfates and process for their production |
| 12/10/1986 | EP0204571A2 Selected difluoro derivatives |
| 12/10/1986 | EP0204529A2 Anti-cancer quinazoline derivatives |
| 12/10/1986 | EP0204476A1 Controlled release delivery system for macromolecules |
| 12/10/1986 | EP0204447A2 Pharmaceutical preparations which may be used for stimulating tear secretion |
| 12/10/1986 | EP0204374A2 Tripeptidic compounds having hypotensive activity |
| 12/10/1986 | EP0204328A2 Novel THF compositions |
| 12/10/1986 | EP0204302A2 Laminin and the production thereof |
| 12/10/1986 | EP0204045A2 Tableted blood plasma microconcentrated coagulation reagents and method of making same |
| 12/09/1986 | US4628045 Immunotherapeutic antiallergic polypeptide agents which bind to basophil immunoglobin Fc receptors |
| 12/09/1986 | US4628044 LHRH antagonists |
| 12/09/1986 | US4628043 Hypothalamic GRF agonists |
| 12/09/1986 | US4627982 Stimulating bone growth in mammals |
| 12/09/1986 | CA1215043A1 Derivatives of a-21978c cyclic peptides and their production |
| 12/04/1986 | WO1986007089A1 Murine hybridoma lym-2 and diagnostic antibody produced thereby |
| 12/04/1986 | WO1986007088A1 Murine hybridoma lym-1 and diagnostic antibody produced thereby |
| 12/04/1986 | WO1986007064A1 Piperidine derivatives |
| 12/04/1986 | WO1986006962A1 Absorption enhancing agents |
| 12/03/1986 | EP0203870A1 Coupling compounds, process for their preparation and their use as mediators in the development of the effects of interferons |
| 12/03/1986 | EP0203580A2 Gamma-IFN as an agent for the inhibition (hindering) of the decay process of bones |
| 12/03/1986 | EP0203555A2 Agent for the functional diagnosis of hypophysis and for the treatment of disorders of the pituitary function |
| 12/03/1986 | EP0203450A2 Derivatives of bicyclic amino acids process for their preparation, agents containing them and their use |
| 12/03/1986 | EP0203418A1 Oligopeptide derivatives, their preparation and their use as tensides with a good tolerance to the skin |
| 12/03/1986 | EP0203382A2 Process for the preparation and purification of alpha-interferon |
| 12/03/1986 | EP0203359A2 Novel peptide having dentinal fluid transport stimulating activity |
| 12/03/1986 | EP0203157A1 Use of purified lipopolysaccharides and their derivatives |
| 12/03/1986 | EP0203089A1 Monoclonal antibodies and their use |
| 12/03/1986 | EP0203088A1 Monoclonal antibodies and their use |
| 12/03/1986 | CN86101394A Process of preparation and use for amino-acid derivative |
| 12/03/1986 | CN85109132A Dna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity |
| 12/02/1986 | US4626545 Hypotensive agents |
| 12/02/1986 | US4626525 Antibiotics, preparation and use of and intermediates therefor |
| 12/02/1986 | US4626524 Antiviral peptides |
| 12/02/1986 | US4626523 GRF analogs II |
| 11/26/1986 | EP0203031A2 Biologically active lysine containing octapeptides |
| 11/26/1986 | EP0202975A2 Soluble interleukin-2 receptor as an indicator of malignancy and a method of assaying the same |
| 11/26/1986 | EP0202853A2 A polypeptide which neutralises the activity of factor VIII inhibitor and a therapeutic composition containing it |
| 11/26/1986 | EP0202577A2 N(Acyldipeptidyl)-aminoglycols |
| 11/26/1986 | EP0202569A1 Nose spray for combating male or female sterility |
| 11/26/1986 | CN86102889A Improved method for man-promoting growth factor c |
| 11/26/1986 | CN86100757A Improvements in on relating to a method for increasing the feed intake of an animal |
| 11/25/1986 | US4625014 Cell-delivery agent |
| 11/25/1986 | US4624944 Human seminal alpha-inhibins |
| 11/25/1986 | US4624943 Aromatic basic-tailed vasopressin antagonists |
| 11/25/1986 | US4624925 Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigens, antibody, and methods |